SCHEMBL21820652

SCHEMBL21820652

N#CC1(c2ccc(Br)cc2)CCCC(=O)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 4/20 0.38
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HSD11B1 P28845 1/20 0.35
LMNA P02545 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TP53 P04637 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13163463 0.90 HSD11B1 (0.40) WDR5PDE4APDE4BPDE4CPDE4D
SCHEMBL5370161 0.84 MEN1 (0.43) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL724260 0.83 MGAT2 (0.36) WDR5NPC1RAB9AALDH1A1MEN1
SCHEMBL2288499 0.80 PDE4A (0.45) WDR5PDE4APDE4BPDE4CPDE4D
SCHEMBL1141221 0.79 WDR5 (0.47) WDR5NPC1RAB9AALDH1A1MEN1
SCHEMBL238163 0.79 WDR5 (0.47) WDR5NPC1RAB9AALDH1A1MEN1
SCHEMBL6209121 0.78 WDR5 (0.48) WDR5NPC1RAB9AALDH1A1MEN1
SCHEMBL3521450 0.78 SLC6A4 (0.52) PDE4APDE4BPDE4CPDE4DOPRM1
SCHEMBL19772418 0.78 SLC6A4 (0.52) PDE4APDE4BPDE4CPDE4DOPRM1
SCHEMBL14441335 0.78 SLC6A4 (0.52) PDE4APDE4BPDE4CPDE4DOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10961266-B2 Chemoselective methylene hydroxylation in aromatic molecules THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2021-03-30 US disclosed
US-10961266-B2 Chemoselective methylene hydroxylation in aromatic molecules THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2021-03-30 US disclosed
US-20200087331-A1 CHEMOSELECTIVE METHYLENE HYDROXYLATION IN AROMATIC MOLECULES THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2020-03-19 US disclosed
US-20200087331-A1 CHEMOSELECTIVE METHYLENE HYDROXYLATION IN AROMATIC MOLECULES THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2020-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10961266-B2 Chemoselective methylene hydroxylation in aromatic molecules PAH, DBH, AHR WDR5 1965/4885PDE4A 1495/4885PDE4B 1596/4885
US-20200087331-A1 CHEMOSELECTIVE METHYLENE HYDROXYLATION IN AROMATIC MOLECULES PAH, DBH, AHR WDR5 1965/4885PDE4A 1495/4885PDE4B 1596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.